Idiopathic intracranial hypertension

1 paper

Trial sponsors

Duke University
1 trialPhase 460 people
Rigmor Højland Jensen
1 trialPhase 438 people
Capital Medical University
1 trialPhase 374 people
St. Luke's-Roosevelt Hospital Center
1 trialPhase 2/3165 people

Latest

3 in 12 months

Brain and Behavior18 Aug

The Neuroprotective Potentials of Dual GIP/GLP1-RA (Tirzepatide): From Preclinical Experiments to Clinical Trials: A Scoping Review

Systematic reviewTirzepatide

Journal of Clinical Medicine13 Aug

Glucagon-like Peptide-1 Receptor Agonists and Chronic Pain: Preclinical Antinociceptive Mechanisms, Indirect Metabolic-Functional Effects, and Clinical Considerations-A Narrative Review

ReviewGLP-1 receptor agonists

AAIC 2025 Abstract25 Dec

Glucagon‐like peptide‐1 receptor agonists for neurological disorders: a systematic review and meta‐analysis

ReviewInterventions